Provided by Tiger Trade Technology Pte. Ltd.

Korro Bio, Inc.

10.49
+0.73007.48%
Post-market: 10.490.00000.00%17:35 EDT
Volume:157.00K
Turnover:1.62M
Market Cap:154.47M
PE:-1.06
High:10.64
Open:9.64
Low:9.50
Close:9.76
52wk High:55.89
52wk Low:5.20
Shares:14.73M
Float Shares:10.53M
Volume Ratio:1.30
T/O Rate:1.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.8800
EPS(LYR):-12.4806
ROE:-97.69%
ROA:-27.95%
PB:1.50
PE(LYR):-0.84

Loading ...

Citigroup Initiates Korro Bio at Buy With $21 Price Target

MT Newswires Live
·
May 18

Korro Bio initiated with a Buy at Citi

TIPRANKS
·
May 18

Analysts Are Bullish on These Healthcare Stocks: Regeneron (REGN), Korro Bio (KRRO)

TIPRANKS
·
May 18

Korro Bio publishes ASGCT 2026 presentation on GalNAc-conjugated RNA editing in AATD models

Reuters
·
May 16

Korro Bio grants new hire option for 3,000 shares at $11.2 each

Reuters
·
May 16

Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 16

JonesResearch upgrades ‘fast-follower’ Korro Bio to Buy

TIPRANKS
·
May 09

Analysts Have Conflicting Sentiments on These Healthcare Companies: CareCloud (CCLD) and Korro Bio (KRRO)

TIPRANKS
·
May 08

Korro Bio Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Korro Bio Q1 EPS $(1.69) Beats $(2.17) Estimate

Benzinga Earnings
·
May 07

Korro Bio posts corporate presentation on RNA-editing genetic medicines pipeline

Reuters
·
May 07

Korro Bio Q1 FY26 net loss narrows to $19.6 million; R&D expenses fall to $12.9 million

Reuters
·
May 07

Korro Bio Inc Qtrly EPS $-1.69

THOMSON REUTERS
·
May 07

Korro Bio Inc - Reports Cash, Cash Equivalents and Marketable Securities of $157.1 Mln as of March 31, 2026

THOMSON REUTERS
·
May 07

Korro Bio Inc - Reports No Collaboration Revenue for Q1 2026

THOMSON REUTERS
·
May 07

Korro Bio Inc - Expects Cash Position to Fund Operations Into Second Half of 2028

THOMSON REUTERS
·
May 07

Korro Bio participates in HCW BioConnect Nasdaq investor conference fireside chat

Reuters
·
May 06

Korro Bio Inc expected to post a loss of $1.84 a share - Earnings Preview

Reuters
·
May 01

Korro Bio to present preclinical KRRO-121 hyperammonemia data at ASGCT meeting

Reuters
·
Apr 16

Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences

THOMSON REUTERS
·
Apr 16